SG Americas Securities LLC Grows Stock Holdings in Masimo Corporation $MASI

SG Americas Securities LLC grew its position in Masimo Corporation (NASDAQ:MASI) by 809.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,766 shares of the medical equipment provider’s stock after buying an additional 13,143 shares during the period. SG Americas Securities LLC’s holdings in Masimo were worth $2,484,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Twin Tree Management LP purchased a new stake in Masimo during the first quarter valued at approximately $29,000. Hilltop National Bank acquired a new position in shares of Masimo during the second quarter worth $37,000. Anderson Financial Strategies LLC purchased a new stake in shares of Masimo during the 1st quarter valued at $49,000. Allworth Financial LP lifted its holdings in shares of Masimo by 72.8% during the 2nd quarter. Allworth Financial LP now owns 387 shares of the medical equipment provider’s stock valued at $65,000 after purchasing an additional 163 shares during the last quarter. Finally, Quarry LP boosted its position in shares of Masimo by 253.5% in the 1st quarter. Quarry LP now owns 449 shares of the medical equipment provider’s stock worth $75,000 after purchasing an additional 322 shares in the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on MASI shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a research report on Wednesday, October 8th. Zacks Research lowered Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Piper Sandler increased their price objective on shares of Masimo from $200.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 6th. Wall Street Zen upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research note on Tuesday, October 14th. Finally, BTIG Research restated a “buy” rating and set a $198.00 price target on shares of Masimo in a research note on Wednesday, November 5th. Five investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Masimo currently has an average rating of “Hold” and an average price target of $188.67.

Masimo Stock Performance

Shares of MASI stock opened at $140.94 on Thursday. Masimo Corporation has a 52-week low of $133.70 and a 52-week high of $194.88. The company has a quick ratio of 1.61, a current ratio of 2.14 and a debt-to-equity ratio of 0.57. The stock has a market cap of $7.57 billion, a PE ratio of -16.54 and a beta of 1.28. The business has a 50-day simple moving average of $145.62 and a 200-day simple moving average of $152.98.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share for the quarter. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%.The company had revenue of $617.00 million during the quarter. On average, equities analysts expect that Masimo Corporation will post 4.1 EPS for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.